1
Return

Titrating Rituximab to Circulating B-Cells Starting From an Ultra-Low Dose for Moderate-to-Severe Pemphigus

delete2026-06-29
delete0
delete
OA
AI
R
Rui Wang
S
Sai Wang
P
Panpan Shang
X
Xixue Chen
R
Ruoyu Li
M
Mingyue Wang *
DOI：10.1155/dth/1828296delete
deleteOriginal
deleteOriginal request for help
deleteShare
deleteSave
Abstract

Abstract

En 中文
Rituximab has been proven effective at a dose of 2 g in moderate-to-severe pemphigus by depleting CD20+B-cell; however, studies have found that 100 mg RTX may suffice to fully suppress CD20+B-cell.
Keywords:
B-cell depletion
pemphigus
rituximab
ultra-low dose

Journal

Dermatologic Therapy cover
Dermatologic Therapy
IF:
3.4
Papers:
4.8K
Citations:
7.1K

Organization

P
peking university first hospital
Scholars:
419
Papers: 110
Citations: 1
Cited Papers

Cited Papers

Citing Papers

Citing Papers